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Methyl bromide (CH3Br) is a colorless and odorless volatile gas, used as an insecticide, fire extinguisher, fumigant,
and refrigerant. Although forbidden since 1987 for domestic use, it is still used in industry, for example, to fumigate
agricultural fields which are for importation in the United States. Here is the case of a 74-year-old man who was
accidentally exposed to methyl bromide after using an old fire extinguisher. Even though he finally survived, he
developed a severe multiple organ failure and spent 2 months in intensive care unit. We present in this report all
the difficulties we had to diagnose this unusual poisoning.
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Methyl bromide (CH3Br) is a colorless and odorless
volatile gas, used as an insecticide, fire extinguisher, fu-
migant, and refrigerant. However, as every halogen gas,
it is toxic both to environment and to humans. As a
consequence, the Montreal agreements have forbidden
its use since 1987. Unfortunately in many countries, es-
pecially developing countries, this gas is still used.
Thirty-eight cases of methyl bromide poisoning were re-
ported in the literature. CH3Br poisoning is usually acci-
dental, and related to chronic, or acute exposure. We
present here a case report of acute accidental methyl
bromide poisoning, responsible for a severe multiple
organ failure (MOF).Case presentation
A 74-year-old man with an unremarkable medical his-
tory was referred to the Roubaix Hospital emergency de-
partment on November 13th 2012. The reasons for his
consultation were headaches, vomiting, walking trouble,
and dysarthria of sudden onset a few hours ago. His vital
signs were blood pressure: 156/57 mmHg, heart rate:
103/min, and body temperature: 95°F (35°C). The first* Correspondence: celine.dedrie@ch-roubaix.fr
Intensive Care Unit, Victor Provo Hospital, Roubaix, France
© 2015 Lecailtel et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.examination of the patient revealed cerebellar signs such
as ataxia, apraxia, and dysarthria. The initial level of
consciousness was normal (Glasgow Coma Score (CGS)
15). The head CT scan was normal, without ischemic or
hemorrhagic stroke. Because of meningeal signs, a lum-
bar puncture was performed and found only 2 cells per
mm3. The neurological investigations were completed by
a brain magnetic resonance imaging (MRI), confirming
the absence of ischemic or hemorrhagic stroke. A brain-
stem stroke was also discarded, and the basilar artery
was permeable.
Few hours later, the patient deteriorated and presented
coma (GCS 7), requiring intubation and mechanical ven-
tilation. He was then transferred to our intensive care
unit. The first lab results revealed a nonspecific inflam-
matory syndrome (white blood cells: 25,000/μL, C-RP:
96 mg/L) and renal failure (creatinine: 266 μmol/L, urea:
13.8 mmol/L). All standard toxic substances were nega-
tive (alcohol, barbiturates, benzodiazepines, tricyclic an-
tidepressants, and carbon monoxide). The chest X-ray
revealed an alveolar infiltrate of the right lung. The renal
ultrasound was normal.
Initial management included mechanical ventilation,
sedation, volemic expansion, broad spectrum antibiotics
to treat a possible meningitis, and intravenous acyclovir
to treat a possible herpetic encephalitis.l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 The patient used the old fire extinguisher to unclog
his sink, containing methyl bromide.
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requiring vasopressive support (norepinephrine). A few
hours later, the patient presented an acute coronary syn-
drome, complicated by severe arrhythmias, namely ven-
tricular fibrillation, responsible for a cardiogenic shock
with a left ventricular ejection fraction (LVEF) at 30%.
Because of multiorgan failure, including cerebral, renal,
pulmonary, and cardiac dysfunctions, several diagnoses
were suspected. Normal levels of complement system’s
proteins and plasma protein electrophoresis were not in
favor of an autoimmune disease. c-ANCA antibodies,
anti-glomerular basement membrane antibodies, antinu-
clear, and lupus anticoagulant antibodies were negative,
allowing to rule out Wegener’s granulomatosis, Goodpas-
ture’s syndrome, and lupus erythematosus. Finally, a
thrombotic microangiopathy was also suspected, but
ADAMST 13 activity was normal. In addition, there was
no hemolytic anemia, neither thrombopenia. It should be
noted that viral serologies such as HIV and B and C hepa-
titis were also negative.
After discussion with the radiologist and the neurolo-
gist, it appeared that the first MRI might have been real-
ized too early. A second one was then performed on
November 16th (day 4). It showed several abnormalities
as follows: hyperintense lesions of thalami (Figure 1a),
dentate nuclei (Figure 1b), posterior white matter in the
brainstem pons, and periaqueductal gray matter of the
midbrain (Figure 1c) on fluid-attenuation inversion re-
covery (FLAIR) and diffusion weighted-sequences.
At day 7, the son of the patient brought us the answer:
an old empty extinguisher (Figure 2). The patient used it
in the morning of his consultation to unclog his sink
and he inhaled the content of the extinguisher, which
contained methyl bromide. A blood sample was sent to
specialized toxicology laboratory in Paris. The methyl
bromide blood level was over 120 mg/L (normal level
<0.05 mg/L). Assuming a 12-day half-life for methyl
bromide [1], his serum bromide was probably much
higher at his admission (7 days before the blood sample).Figure 1 Brain abnormalities of a patient. (a) MRI showing hyperintense
lesions of dentate nuclei. (c) Same patient; MRI showing lesions of the pos
gray matter of the midbrain.Four weeks later, methyl bromide was still positive in
the patient’s blood (Figure 3).
Several authors have studied methyl bromide’s neuro-
toxicity and reported similar brain MRI results. Bilateral
strikingly symmetrical high signal intensity on T2-
weighted and FLAIR sequences have been reported in
the bilateral dentate nuclei of the cerebellum, periven-
tricular area of the fourth ventricle, dorsal medulla (in-
ferior olivary nuclei, restiform bodies, vestibular nuclei),
dorsal pons, periaqueductal gray matter, superior and in-
ferior colliculi, posterior putamen, subthalamic nuclei,lesions of thalami. (b) Same patient; MRI showing hyperintense
terior white matter in the brainstem pons and in the periaqueductal
Figure 3 Evolution of the methyl bromide plasma levels.
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T1-weighted images and devoid of mass effect. Post-
gadolinium studies demonstrated no enhancement [2-6].
These lesions were thought to be related to local injury
due to ischemia resulting from vasospasm, to increased
axonal and interstitial water content, and also to a direct
effect of the methyl bromide on Purkinje cells’ nucleic
acid [7,8].
Evolution
As regards to the cardiovascular system, the patient pre-
sented an acute coronary syndrome at day 2, responsible
for a cardiogenic shock. The diagnosis was made based on
the combination of an elevated troponin up to 54 μg/L
and changes in the 12-lead electrocardiogram. There was
indeed a de novo ST elevation and a Pardee wave in the
inferolateral territory, with mirror images in the anterior
territory. The transthoracic echocardiography revealed
kinetics abnormalities in the corresponding territories and
a decreased left ventricle ejection fraction at 30%. The pa-
tient also presented ventricular fibrillation, reversed after
three external electric shocks. Given the fact that the pa-
tient was highly unstable, presented acute renal failure,
and in the hypothesis of a septic shock, we decided not to
perform an angiocoronarography immediately. The car-
diogenic shock was controlled after 4 days of cardiotropic
treatment by dobutamine, and the electrocardiogram was
back to anterior state within 48 h, under cover of a treat-
ment by double platelet anti-aggregation. One month
later, the LVEF increased at 50%.
The angiocoronarography performed around day 40
found normal coronary arteries. The assumption of a
myocardial infarction induced by the methyl bromide
himself was then not confirmed. The major etiological hy-
pothesis for this cardiac and/or coronary distress is a side
effect of the severe initial shock with low cardiac output.
Indeed, initial cardiac ultrasound showed localized kinet-
ics abnormality, well correlated with electrocardiogram,which did not suggest a stress cardiomyopathy such as
Takotsubo (no contrast between apex and basis of the left
ventricle). A direct cardiotoxicity of the methyl bromide is
quite unlikely because no similar case has been described
in the literature.
As regards to renal failure, the urinary balance showed
a proteinuria at 2.15 g/day. The renal ultrasound showed
no obstruction of the urinary tract, two kidneys of nor-
mal size, and a good corticomedullary differentiation.
The renal function got worse to reach a real anuria with
creatininemia at 575 μmol/L and ureamia at 38,2 mmol/L.
Extrarenal epuration was required for 11 days. We used a
continuous venovenous hemofiltration instead of intermit-
tent dialysis because of hemodynamic unstability. A nor-
mal renal function was finally reached in 16 days, with a
creatininemia at 90 μmol/L, and a normal urinary output.
This renal failure seems to be of renal type. On the first
blood sample from the emergency ward, creatinine level is
already more increased than the urea is. The natriuresis
was never locked. Moreover, the early volemic expansion
and hemodynamic stabilization had no effect on renal
function and diuresis. This renal failure can easily be ex-
plained by the methyl bromide himself [9].
As regards to respiratory failure, ventilator-associated
pneumonia was suspected at day 4. The patient pre-
sented hyperthermia at 101.3°F (38.5°C), an important
inflammatory syndrome with C-RP at 195 mg/L and a
right alveolar infiltrate on the chest X-ray. Two days
later, in spite of a broad-spectrum antimicrobial treat-
ment (Tazocilline), it progressed to acute respiratory dis-
tress syndrome (ARDS) with a PaO2/FiO2 ratio at 80
and bilateral diffuse alveolar syndrome on the chest X-ray.
There was no argument in favor of a cardiogenic pulmon-
ary oedema, in spite of the concomitant ventricular dys-
function, because the left ventricular filling pressures were
low. The patient required specific ARDS ventilation and
curarization. Finally, ARDS quickly resolved, and the pa-
tient did not require prone positioning. The pulmonary
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pneumothorax under mechanical ventilation, which had
to be been drained by a chest tube.
All the respiratory events were obviously not the result
of direct injury of the intoxication but were induced by
the neurological injury, requiring intubation and mech-
anical ventilation.
Delayed weaning from the ventilator was partly re-
lated to ventilator-associated pneumonia. In addition,
the patient presented a polyneuropathy with tetrapare-
sia. ICU-acquired weakness or “critical illness poly-
neuropathy” was confirmed by an electromyogram
showing a peripherical neurogenic disturbance. It was
certainly favored by 56 days of mechanical ventilation
and the severity of the multiple organ failure [10].
However, this kind of peripheral neuropathy has also
been frequently described in cases of methyl bromide
poisoning [11-14]. On top of this, the methyl bromide
intoxication resulted in central neurological effects,
such as delayed awakening, and alertness disorders.
Moreover, the patient experienced swallowing disor-
ders, probably due to the methyl bromide intoxication
itself [3,15]. A percutaneous tracheotomy was per-
formed because of weaning difficulties.
Finally, the patient was decanulated after 56 days of
mechanical ventilation. A brain MRI, performed 6 months
later, showed that most of the lesions had improved. It
remained only sequels on the left internal capsule and spe-
cifically the thalamus and the dentate nucleus. According
to the literature, brain MRI lesions due to methyl bromide
toxicity are frequently reversible [7,8,16]. He has been
transferred to a rehabilitation department specialized in
rehabilitation of neurological patients. To date, he is back
home. After hours of physical and speech therapy, he still
faces sequels such as dysarthria and ataxia and needs a
Zimmer to walk by himself.
As far as pathophysiology is concerned, several mech-
anisms seem to be the cause of the methyl bromide
toxicity. Most of the authors have described a cellular
toxic effect. Indeed, following a methylation reaction,
the methyl bromide conjugates itself with glutathione
to make methylglutathione, which is highly toxic for
the respiratory chain [17-20]. A second cause often
described is the modulation of the inhibitory neuro-
transmitter γ-aminobutyric acid receptor within the
cerebellar and vestibular systems [9,16,21]. A third hy-
pothesis attributes toxicity to methyl bromide metabo-
lites such as methanethiol and formaldehyde [17,19].
Another suggested mechanism is that methyl bromide
rapidly inhibits creatine kinase activity in all regions of
the brain and in other target organs. Creatine kinase is
an enzyme catalyzing the conversion of adenosine tri-
phosphate and creatine to adenosine diphosphate and
phosphocreatine [22,23].Conclusion
Cases of methyl bromide poisoning have become rare
since his prohibition in 1987 thanks to the Montreal
agreements. These cases being rare, it makes it even
harder to establish the proper diagnosis. The clinical
presentation of the acute methyl bromide poisoning can
be tricky. However, common clinical signs have been re-
ported, such as headaches, vomitings, cerebellar signs,
and seizures [24]. Our patient presented all of them, ex-
cept for seizures, which are however quite frequent in
this intoxication [4]. Several complications have been de-
scribed such as ARDS and acute kidney injury. Our pa-
tient experienced all these complications. Some authors
reported the use of extrarenal epuration [25,26], but they
highlight the importance of the earliness of this treat-
ment. In chronic intoxication, signs are quite different.
Neuropathies, liver insufficiencies, kidney insufficiencies,
and neuropsychiatric disorders were reported [2].
However, no antidote is available. Many treatments
have been tested such as Glucagon or N-Acetylcysteine
but are ineffective [27,28].
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